Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) EBIT (2020 - 2025)

Beauty Health (SKIN) has disclosed EBIT for 6 consecutive years, with -$6.2 million as the latest value for Q3 2025.

  • On a quarterly basis, EBIT rose 70.99% to -$6.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$28.1 million, a 64.39% increase, with the full-year FY2024 number at -$67.8 million, up 48.23% from a year prior.
  • EBIT was -$6.2 million for Q3 2025 at Beauty Health, down from -$2.7 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$602319.0 in Q1 2021 to a low of -$82.1 million in Q3 2023.
  • A 5-year average of -$15.0 million and a median of -$12.0 million in 2025 define the central range for EBIT.
  • Peak YoY movement for EBIT: plummeted 2226.51% in 2022, then skyrocketed 87.79% in 2025.
  • Beauty Health's EBIT stood at -$7.5 million in 2021, then surged by 67.43% to -$2.4 million in 2022, then plummeted by 650.0% to -$18.4 million in 2023, then soared by 61.02% to -$7.2 million in 2024, then grew by 12.78% to -$6.2 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's EBIT are -$6.2 million (Q3 2025), -$2.7 million (Q2 2025), and -$12.0 million (Q1 2025).